|
Last updates: |
|
ENTER
- Steering EU public health
- Ensuring health security
- Preparedness and response
- Serious cross-border threats to health
- Lifting COVID-19 containment measures — roadmap
- Supply of crisis-relevant medical countermeasures in the event of a public health emergency at the European Union level
- European Medicines Agency – reinforced role in crisis preparedness and management for medicinal products and medical devices
- Blood, tissues and organs
- Safe human tissues & cells for transplantation (until 2027)
- Quality standards to be met by blood banks
- Quality and safety of substances of human origin intended for human application
- Quality and safety of organs intended for transplantation
- Human blood and blood components – maintaining standards (until 2027)
- Preparedness and response
- Improving healthcare systems
- Cross-border healthcare
- Healthcare workforce
- Patient safety
- Health technology assessment
- eHealth
- Risk assessment
- The precautionary principle
- Making critical entities more resilient
- Protecting health and the environment from persistent organic pollutants
- Scientific committees
- Disease prevention
- Antimicrobial resistance
- Communicable diseases
- Vaccination
- Major and chronic diseases
- Rare diseases
- Endocrine disruptors
- Health in society
- Workers' health
- Exposure to artificial optical radiation
- Protecting pregnant workers and new mothers
- Minimum health and safety standards while using work equipment
- Health and safety of workers in the extractive industries
- Health and safety of workers: conditions applicable to the workplace
- Health and safety at work — general rules
- Health and safety at work: exposure to noise
- Limiting the exposure of workers to risks from electromagnetic fields (from July 2016)
- Provision of health and safety signs at work
- Protection of young people at work
- Protection of workers from exposure to biological agents
- Workplace health and safety for temporary workers
- Workers’ health and safety in the mineral-extracting industries
- Use of personal protective equipment
- Fishing vessels — health and safety of workers on board
- Equal treatment of temporary agency workers
- Advisory Committee on Safety and Health at Work (ACSH)
- Temporary and mobile work sites
- Safety at work - manual handling of loads
- Preventing and reducing chemically induced illnesses and injuries at work
- Exposure to chemical agents
- Exposure to carcinogens, mutagens or reprotoxic substances at work
- Exposure to asbestos: worker protection
- Workers' health
- Promoting good health
- Nutrition and physical activity
- Alcohol
- Tobacco
- Pharmaceuticals
- Medicines for human use
- Export of generic medicines to developing countries: compulsory licences
- High safety standards and streamlined procedures for EU clinical trials
- Medicines for rare diseases - orphan drugs
- Medicinal products for paediatric use
- Ingredients used in medicines – guidance for importers and distributors
- Safe medicines for Europeans — European Medicines Agency
- European Pharmacopoeia
- European Medicines Agency – reinforced role in crisis preparedness and management for medicinal products and medical devices
- Clinical Trials
- EU rules on the authorisation, import and production of medicines for humans
- EU rules for new medical products based on genes and cells
- Ensuring the safety and performance of medical devices
- Ensuring the safety and performance of in vitro diagnostic medical devices
- Supplementary protection certificates for medicines and plant protection products
- Transparency of decisions regulating the prices and reimbursement of medicinal products in European Union Member States
- Medicines for veterinary use
- Medicines for human use
- Archived summaries
- Executive Agency for Health and Consumers
- Exposure to electromagnetic fields
- Exposure to electromagnetic fields
- Exposure to environmental tobacco smoke (Proposal)
- Preventing HIV/AIDS (Council conclusions of 2005)
- Preparation and marketing of medicated feedingstuffs for animals
- Preparing for an influenza pandemic and other health threats
- Systems for tobacco traceability and security features
- The future of health care and care for the elderly: guaranteeing accessibility, quality and financial viability
- Telemedicine systems and services
- Scientific Committees for consumer safety, public health and the environment
- Second programme of Community action in the field of health (2008-2013)
- Suitability of blood donors
- The fight against bioterrorism (communication)
- Multi-annual programme of action for health (2014-2020) (Proposal)
- Network for the surveillance and control of communicable diseases
- New Community health strategy
- Nutrition and health
- Obesity, nutrition and physical activity
- Organ donation and transplantation in the European Union
- Antibiotic resistance
- A new strategic approach to health for the EU (2008-2013)
- A safe and healthy work environment
- Ban on smoking in public places
- Action against Cancer: European Partnership (2009-2013)
- Action on HIV/AIDS in the European Union and neighbouring countries 2006 - 2009
- BSE: state of play in March 2003
- Action plan on Organ Donation and Transplantation
- Ensuring medical devices are safe and efficient for patients
- EU scientific committees on consumer safety (SCCS) & on health, environmental and emerging risks (SCHEER)
- EU digital COVID certificate
- Environment and Health Action Plan 2004-2010
- Environment and health strategy
- EU rules on the authorisation, import and production of veterinary medicines
- Combating HIV/AIDS in the European Union and neighbouring countries (2009-2013)
- Combating serious cross-border threats to health
- Combating stigma and discrimination in relation to mental health
- Combating stress and depression-related problems
- Community action in the field of mental health
- Drinking and driving: Maximum authorised level of alcohol in the blood
- Drinking of alcohol by young people
- Community strategy against antimicrobial resistance
- Community strategy to reduce alcohol-related harm (Council conclusions - 2001)
- Community Tobacco Fund: information programmes
- e-Health: improving health and healthcare through the use of information and communications technologies
- Early warning and response system for the prevention and control of communicable diseases
- Women's health
- Rare diseases: Europe’s challenges
- Safe active implantable medical devices
- Public-private partnership in innovative medicines
- Radiological protection for persons undergoing medical examination or treatment
- Modern, responsive and sustainable health systems
- Informing the general public in the event of a radiological emergency
- Manufacture, presentation and sale of tobacco products
- Green Paper on Mental Health
- Green Paper on promoting healthy diets and physical activity
- Green Paper on promoting smoke-free areas in the European Union
- Medicines and investigational medicines for human use — safe production
- Health for Growth: EU health programme (2014-20)
- Healthy diet for a healthy life
- Programme of Community action in the field of public health (2003-2008)
- Promoting cancer screening in the EU
